U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT PRODUCTS

333 Pages | 115 Exhibits | 2010 Analysis | Forecasts Through 2014 Product Family: Market Reports




OVERVIEW:
Cardiac rhythm disorders-also called arrhythmias or dysrhythmias-encompass a variety of relatively common chronic conditions characterized by recurrent distortions in the electrical and contractile activity of the heart, which may cause clinically significant and progressive hemodynamic deficits and cardiopulmonary impairment, and lead to the onset of catastrophic events such as stroke or cardiac arrest. Acute and chronic arrhythmias afflict cumulatively more than 8 million people in the U.S., accounting for over 20% of all medical conditions treated by cardiologists. Furthermore, each year cardiac rhythm disorders represent a primary or secondary cause of death in nearly 600,000 American mortalities and prompt approximately 1.5 million hospitalizations, resulting in an estimated $35 billion in direct and indirect annual healthcare costs.

The scope of this report covers critical device-based arrhythmia diagnostic and therapeutic systems that are routinely employed in the management of patients with such conditions as debilitating bradycardia and heart block, life-threatening atrial and ventricular tachyarrhythmias, cardiac asynchrony associated with progressing heart failure, arrhythmia-induced cardiogenic shock and sudden cardiac arrest.

The U.S. Cardiac Rhythm Management Products Market totaled more than $7.9 billion in 2009 and despite prevailing economic conditions is expected to grow at a healthy 4.8% compound annual rate, reaching more than $10.0 billion in 2014.

This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging technology and opportunities. Product areas include: electrocardiography systems, diagnostic electrophysiology transcatheter systems, cardiac pacemakers, implantable cardioverter defibrillator systems, cardiac resynchronization therapy systems, automated external defibrillator systems, transcatheter arrhythmia ablation systems, and directed-energy based surgical ablation systems.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Heart Anatomy and Physiology 
ii. Cardiovascular Disease 
	a. Arrhythmia 
	b. Types of Arrythmia 
	c. Supraventricular Arrythmia/Tachycardia 
	d. Atrial Fibrillation 
	e. Atrial Flutter 
	f. Paroxysmal Supraventricular Tachycardia 
	g. Ventricular Arrhythmia 
	h. Bradycardia 
iii. Treatment 
	a. Medication 
	b. Cardiac Resynchronization Devices, Implantable Cardioverter Defibrillators, and Pacemakers 
	c. Cardiac Surgery 
	d. Catheter Ablation 
	e. Vagal Maneuvers 
iv. Combined Market Analysis 
v. Methodology 

Exhibit ES-1: Incidence and Prevalence of Common Cardiac Arrhythmias and Associated Disorders, 2009 and 2014 
Exhibit ES-2: Diagram of the Heart 
Exhibit ES-3: Cardiac Rhythm Management Procedures, Combined Procedure Volumes Forecast, 2008-2014 
Exhibit ES-4: Cardiac Rhythm Management Products, Combined Market Forecast, 2008-2014 
Exhibit ES-5: Cardiac Rhythm Management Products, Combined Market Forecast, by Segment, 2008-2014 
Exhibit ES-6: 2009, Cardiac Rhythm Management Products Market, Share by Segment 
Exhibit ES-7: 2014, Cardiac Rhythm Management Products Market, Share by Segment 
 
1. CARDIAC RHYTHM DISORDERS OVERVIEW

1.1 Heart Anatomy and Physiology 
	1.1.1 The Rhythmic Beating of the Heart 
	1.1.2 The Blood Circulatory System 
	1.1.3 The Cardiac Conduction System 
1.2 Cardiovascular Disease 
1.3 Arrhythmia 
	1.3.1 Types of Arrythmia 
		1.3.1.1 Supraventricular Arrythmia/Tachycardia 
			1.3.1.1.1 Atrial Fibrillation 
			1.3.1.1.2 Atrial Flutter 
			1.3.1.1.3 Paroxysmal Supraventricular Tachycardia 
		1.3.1.2 Ventricular Arrhythmia 
		1.3.1.3 Bradycardia 
	1.3.2 Symptoms 
	1.3.3 Causes and Risk Factors 
	1.3.4 Diagnosis 
	1.3.5 Treatment 
		1.3.5.1 Medication 
		1.3.5.2 Cardiac Resynchronization Devices, Implantable Cardioverter Defibrillators, and Pacemakers 
		1.3.5.3 Cardiac Surgery 
		1.3.5.4 Catheter Ablation 
		1.3.5.5 Vagal Maneuvers 
	
Exhibit 1-1: Incidence and Prevalence of Common Cardiac Arrhythmias and Associated Disorders, 2009 and 2014 
Exhibit 1-2: Diagram of the Heart 

2. CARDIAC RHYTHM DISORDERS DIAGNOSIS AND MANAGEMENT

2.1 Clinical Diagnosis of Cardiac Rhythm Disorders 
	2.1.1 Electrocardiography 
		2.1.1.1 Resting Electrocardiography 
		2.1.1.2 Exercise/Stress Testing 
		2.1.1.3 Holter Monitoring 
		2.1.1.4 Transtelephonic Event Recording 
		2.1.1.5 Signal-Averaged Electrocardiography 
	2.1.2 Tilt-Table Testing 
	2.1.3 Electrophysiology Studies 
		2.1.3.1 Conventional Electrophysiology Studies 
		2.1.3.2 Advanced Electrophysiology Mapping/Navigation 
2.2 Therapeutic Management of Cardiac Rhythm Disorders 
	2.2.1 Antiarrhythmic Pharmacotherapy 
	2.2.2 Implantable Device-Based Arrhythmia Therapy 
		2.2.2.1 Cardiac Pacemakers 
			2.2.2.1.1 Pacemaker Types and Coding 
				2.2.2.1.1.1 Fixed-Rate and Demand 
				2.2.2.1.1.2 Single-Chamber and Dual-Chamber 
				2.2.2.1.1.3 Rate-Responsive Pacing 
				2.2.2.1.1.4 Magnetic Resonance Imaging-Compatible 
				2.2.2.1.1.5 Leads and Electrodes 
			2.2.2.1.2 Indications for Implantation 
			2.2.2.1.3 Selection and Programming 
			2.2.2.1.4 Temporary Pacing Systems 
		2.2.2.2 Implantable Cardioverter Defibrillators 
			2.2.2.2.1 Technology and Implantation 
			2.2.2.2.2 Clinical Data 
			2.2.2.2.3 Selection and Programming 
		2.2.2.3 Cardiac Resynchronization Therapy 
			2.2.2.3.1 Technology and Implantation 
			2.2.2.3.2 Clinical Data 
			2.2.2.3.3 Indications and Contraindications 
			2.2.2.3.4 Emerging Applications and Current Clinical Trials 
				2.2.2.3.4.1 Boston Scientific 
				2.2.2.3.4.2 Medtronic 
				2.2.2.3.4.3 St. Jude Medical 
	2.2.3 Automated External Defibrillation 
		2.2.3.1 Technology 
		2.2.3.2 End-Users 
	2.2.4 Arrhythmia Ablation 
		2.2.4.1 Transcatheter Ablation 
			2.2.4.1.1 Percutaneous Transcatheter Ablation of Atrial Fibrillation 
		2.2.4.2 Directed Energy-Based Surgical Ablation of Atrial Fibrillation 

Exhibit 2-1: Normal Electrocardiogram Trace 
Exhibit 2-2: Selected Major Cardiac Rhythm Disorders and Current Treatment Protocols 
Exhibit 2-3: Vaughan-Williams Classification of Antiarrhythmic Drugs, by Action Mechanism 
Exhibit 2-4: NBG Codes for Implantable Cardiac Pacemakers 
Exhibit 2-5: Comparison of Rate-Adaptive Pacing Modalities 
Exhibit 2-6: Selected Rate-Adaptive Pacing Modalities for the Management of Atrial and Endless Loop Tachycardias 
Exhibit 2-7: NBD Codes for Implantable Cardioverter Defibrillators 
Exhibit 2-8: Selected Implantable Cardioverter Defibrillator Features and Labeling 
Exhibit 2-9: Selected Major Cardiac Resynchronization Therapy Clinical Trials 
Exhibit 2-10: Indications and Contraindications for Cardiac Resynchronization Therapy Devices 
Exhibit 2-11: Expanded Recommendations for Cardiac Resynchronization Therapy in Patients with Heart Failure 

3. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

3.1 Cardiac Rhythm Diagnostic Systems Market 
	3.1.1 Electrocardiogram Systems 
		3.1.1.1 Selected Products 
			3.1.1.1.1 Cardiac Science 
			3.1.1.1.2 GE Healthcare/General Electric 
			3.1.1.1.3 Philips Healthcare/Royal Philips Electronics 
		3.1.1.2 Procedure Volumes 
		3.1.1.3 Market Analysis 
		3.1.1.4 Competitive Analysis 
	3.1.2 Diagnostic Electrophysiology Catheters 
		3.1.2.1 Selected Products 
			3.1.2.1.1 Bard Electrophysiology/C.R. Bard 
			3.1.2.1.2 Biosense Webster/Johnson & Johnson 
			3.1.2.1.3 Boston Scientific 
			3.1.2.1.4 St. Jude Medical 
		3.1.2.2 Procedure Volumes 
		3.1.2.3 Market Analysis 
		3.1.2.4 Competitive Analysis 
3.2 Cardiac Rhythm Therapy Systems Market 
	3.2.1 Cardiac Pacemakers 
		3.2.1.1 Selected Products 
			3.2.1.1.1 Boston Scientific 
			3.2.1.1.2 Medtronic 
			3.2.1.1.3 St. Jude Medical 
		3.2.1.2 Procedure Volumes 
		3.2.1.3 Market Analysis 
		3.2.1.4 Competitive Analysis 
	3.2.2 Implantable Cardioverter Defibrillator Systems 
		3.2.2.1 Selected Products 
			3.2.2.1.1 Boston Scientific 
			3.2.2.1.2 Medtronic 
			3.2.2.1.3 St. Jude Medical 
		3.2.2.2 Procedure Volumes 
		3.2.2.3 Market Analysis 
		3.2.2.4 Competitive Analysis 
	3.2.3 Cardiac Resynchronization Therapy Systems 
		3.2.3.1 Selected Products 
			3.2.3.1.1 Boston Scientific 
			3.2.3.1.2 Medtronic 
			3.2.3.1.3 St. Jude Medical 
		3.2.3.2 Procedure Volumes 
		3.2.3.3 Market Analysis 
		3.2.3.4 Competitive Analysis 
	3.2.4 Automated External Defibrillator Systems 
		3.2.4.1 Selected Products 
			3.2.4.1.1 Cardiac Science 
			3.2.4.1.2 Physio-Control/Medtronic 
			3.2.4.1.3 Philips Healthcare/Royal Philips Electronics 
			3.2.4.1.4 ZOLL Medical 
		3.2.4.2 Procedure Volumes 
		3.2.4.3 Market Analysis 
		3.2.4.4 Competitive Analysis 
	3.2.5 Arrhythmia Ablation Products 
		3.2.5.1 Catheter Ablation Systems 
			3.2.5.1.1 Selected Products 
				3.2.5.1.1.1 Biosense Webster/Johnson & Johnson 
				3.2.5.1.1.2 Boston Scientific 
				3.2.5.1.1.3 Medtronic 
			3.2.5.1.2 Procedure Volumes 
			3.2.5.1.3 Market Analysis 
			3.2.5.1.4 Competitive Analysis 
		3.2.5.2 Directed Energy-Based Surgical Ablation Systems 
			3.2.5.2.1 Selected Products 
				3.2.5.2.1.1 AtriCure 
				3.2.5.2.1.2 ATS Medical/Medtronic 
				3.2.5.2.1.3 Medtronic 
			3.2.5.2.2 Procedure Volumes 
			3.2.5.2.3 Market Analysis 
			3.2.5.2.4 Competitive Analysis 
3.3 Combined Market Analysis

Exhibit 3-1: Diagnostic Electrocardiogram and Transcatheter Electrophysiology Examinations,  Procedure Volumes Forecast, 2008-2014 
Exhibit 3-2: Diagnostic Electrocardiogram and Transcatheter Electrophysiology Systems,  Combined Market Forecast, 2008-2014 
Exhibit 3-3: Cardiac Science's Burdick Atria 3100 and Atria 6100 Electrocardiogram Systems 
Exhibit 3-4: Cardiac Science's Burdick Universal Electrocardiogram System 
Exhibit 3-5: Cardiac Science's Quinton Q-Stress Cardiac Stress Testing System 
Exhibit 3-6: Cardiac Science's Burdick HeartStride Cardiac Stress  Testing System 
Exhibit 3-7: GE Healthcare's MAC Resting Electrocardiogram System 
Exhibit 3-8: Philips Healthcare's PageWriter TC50 and TC70 Cardiographs 
Exhibit 3-9: Philips Healthcare's PageWriter Trim Line of Cardiographs 
Exhibit 3-10: Electrocardiogram Examinations, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-11: Electrocardiogram Systems, Market Forecast, 2008-2014 
Exhibit 3-12: 2009, Electrocardiogram Systems Market, Share by Supplier 
Exhibit 3-13: Bard Electrophysiology's Orbiter PV Variable Loop Mapping Catheter 
Exhibit 3-14: Bard Electrophysiology's Conforma Bi-Directional Diagnostic Catheter  
Exhibit 3-15: Bard Electrophysiology's 20-Pole Fixed Curve Specialty Catheter 
Exhibit 3-16: Bard Electrophysiology's CS Assist Specialty Catheter 
Exhibit 3-17: Biosense Webster's LASSO Circular Mapping Catheter 
Exhibit 3-18: Biosense Webster's PentaRay High-Density Mapping Catheter 
Exhibit 3-19: Biosense Webster's HALO XP Twenty Electrode Catheter 
Exhibit 3-20: Boston Scientific's Constellation Full Contact Mapping Catheter 
Exhibit 3-21: Boston Scientific's AFocus Steerable Diagnostic Catheter 
Exhibit 3-22: Boston Scientific's Blazer Dx-20 Bidirectional Duodecapolar Diagnostic Catheter 
Exhibit 3-23: Boston Scientific's Polaris Dx Steerable Diagnostic Catheter 
Exhibit 3-24: Boston Scientific's Inquiry HIS Diagnostic Catheter 
Exhibit 3-25: St. Jude Medical's Reflexion HD Mapping Catheter 
Exhibit 3-26: St. Jude Medical's Reflexion Spiral Variable Radius Catheter 
Exhibit 3-27: St. Jude Medical's Inquiry Optima PLUS Diagnostic Catheter 
Exhibit 3-28: Diagnostic Electrophysiology Catheter Studies, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-29: Diagnostic Electrophysiology Catheters, Market Forecast, 2008-2014 
Exhibit 3-30: 2009, Diagnostic Electrophysiology Catheters Market, Share by Supplier 
Exhibit 3-31: Cardiac Rhythm Therapy, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-32: Cardiac Rhythm Therapy Products, Market Forecast, 2008-2014 
Exhibit 3-33: Implantable Pulse Generator Implantation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-34: Implantable Pulse Generators, Market Forecast, 2008-2014 
Exhibit 3-35: Boston Scientific's ALTRUA Line of Pacemakers 
Exhibit 3-36: Medtronic's Adapta and EnRhythm Pacemakers, and CareLink Remote Monitoring Network 
Exhibit 3-37: Medtronic's Revo MRI SureScan Pacemaker 
Exhibit 3-38: St. Jude Medical's ACCENT RF Pacemaker 
Exhibit 3-39: St. Jude Medical's ACCENT MRI Pacemaker 
Exhibit 3-40: St. Jude Medical's AFFINITY DR Pacemaker 
Exhibit 3-41: St. Jude Medical's IDENTITY ADx DR Pacemaker 
Exhibit 3-42: Cardiac Pacemaker Implantation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-43: Cardiac Pacemaker Systems, Market Forecast, 2008-2014 
Exhibit 3-44: 2009, Cardiac Pacemaker Systems Market, Share by Supplier 
Exhibit 3-45: Boston Scientific's CONFIENT, TELIGEN, and VITALITY Implantable Cardioverter Defibrillators 
Exhibit 3-46: Medtronic's Maximo II and Secura Implantable Cardioverter Defibrillators 
Exhibit 3-47: St. Jude Medical's Fortify Implantable Cardioverter Defibrillator and Unify Cardiac Resynchronization Therapy Defibrillator 
Exhibit 3-48: Implantable Cardioverter Defibrillator Implantation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-49: Implantable Cardioverter Defibrillators, Market Forecast, 2008-2014 
Exhibit 3-50: 2009, Implantable Cardioverter Defibrillators Market, Share by Supplier 
Exhibit 3-51: Boston Scientific's COGNIS Cardiac Resynchronization  Therapy Defibrillator 
Exhibit 3-52: Selected Screenshot of Boston Scientific's CONTAK RENEWAL 3 RF Software 
Exhibit 3-53: Boston Scientific's CONTAK RENEWAL TR's Independent Channels Feature 
Exhibit 3-54: Medtronic's Maximo Cardiac Resynchronization Therapy Defibrillator 
Exhibit 3-55: St. Jude Medical's Anthem, Atlas+, Frontier II, and Promote Plus Cardiac Resynchronization Therapy Devices 
Exhibit 3-56: Cardiac Resynchronization Therapy Device Implantation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-57: Cardiac Resynchronization Therapy Devices, Market Forecast, 2008-2014 
Exhibit 3-58: 2009, Cardiac Resynchronization Therapy Devices Market, Share by Supplier 
Exhibit 3-59: Cardiac Science's Powerheart AED G3 Plus and  Powerheart AED G3 Trainer 
Exhibit 3-60: Physio-Control's LIFEPAK 15 and LIFEPAK 1000 Automated External Defibrillators 
Exhibit 3-61: Physio-Control's LIFEPAK CR Plus Automated External Defibrillator 
Exhibit 3-62: Philips Healthcare's HeartStart OnSite Automated External Defibrillator 
Exhibit 3-63: Philips Healthcare's HeartStart Automated External Defibrillator Trainer 
Exhibit 3-64: Philips Healthcare's HeartStart FRx and FR2+ Automated External Defibrillators 
Exhibit 3-65: Philips Healthcare's HeartStart Home Automated External Defibrillator 
Exhibit 3-66: ZOLL Medical's LifeVest Wearable Defibrillator 
Exhibit 3-67: ZOLL Medical's AED Plus Defibrillator 
Exhibit 3-68: ZOLL Medical's AED Pro Defibrillator 
Exhibit 3-69: ZOLL Medical's R Series Automated External Defibrillators 
Exhibit 3-70: Automatic External Defibrillation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-71: Automated External Defibrillators, Market Forecast, 2008-2014 
Exhibit 3-72: 2009, Automated External Defibrillators Market, Share by Supplier 
Exhibit 3-73: Biosense Webster's Navistar ThermoCool Irrigated Tip Catheter/Ablation System 
Exhibit 3-74: Biosense Webster's CARTO 3 System 
Exhibit 3-75: Boston Scientific's Blazer II XP Temperature Ablation Catheter 
Exhibit 3-76: Boston Scientific's SteeroCath-Dx Bi-Directional Steerable Diagnostic Catheter 
Exhibit 3-77: Medtronic's Arctic Front CryoAblation Catheter System 
Exhibit 3-78: Medtronic's Freezor Cardiac CryoAblation Catheter 
Exhibit 3-79: Percutaneous Catheter Ablation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-80: Percutaneous Catheter Ablation Systems, Market Forecast, 2008-2014 
Exhibit 3-81: 2009, Percutaneous Catheter Ablation Systems Market, Share by Supplier 
Exhibit 3-82: AtriCure's Cryo1 Cryo-Ablation Probe 
Exhibit 3-83: AtriCure's Isolator Multifunctional Pens 
Exhibit 3-84: AtriCure's AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System 
Exhibit 3-85: ATS Medical's ATS CryoMaze Surgical Ablation System 
Exhibit 3-86: Medtronic's Cardioblate BP2 and Gemini Irrigated RF Surgical Ablation Systems 
Exhibit 3-87: Directed Energy-Based Surgical Ablation, Procedure Volumes Forecast, 2008-2014 
Exhibit 3-88: Directed Energy-Based Surgical Ablation Systems, Market Forecast, 2008-2014 
Exhibit 3-89: 2009, Directed Energy-Based Surgical Ablation Systems Market, Share by Supplier 
Exhibit 3-90: Cardiac Rhythm Management Procedures, Combined Procedure Volumes Forecast, 2008-2014 
Exhibit 3-91: Cardiac Rhythm Management Products, Combined Market Forecast, 2008-2014 
Exhibit 3-92: Cardiac Rhythm Management Products, Combined Market Forecast, by Segment, 2008-2014 
Exhibit 3-93: 2009, Cardiac Rhythm Management Products Market, Share by Segment 
Exhibit 3-94: 2014, Cardiac Rhythm Management Products Market, Share by Segment 
Exhibit 3-95: 2009, Combined Cardiac Rhythm Management Products Market, Share by Supplier 

4. COMPANY PROFILES

4.1 AtriCure, Inc. 
4.2 ATS Medical, Inc./Medtronic, Inc. 
4.3 Bard Electrophysiology/C.R. Bard, Inc. 
4.4 Biosense Webster, Inc./Johnson & Johnson 
4.5 Boston Scientific Corporation 
4.6 GE Healthcare/General Electric Company 
4.7 Medtronic, Inc. 
4.8 Philips Healthcare/Royal Philips Electronics NV 
4.9 St. Jude Medical, Inc. 
4.10 ZOLL Medical Corporation 


APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. AtriCure, Inc.
  2. ATS Medical, Inc./Medtronic, Inc.
  3. Bard Electrophysiology/C.R. Bard, Inc.
  4. Biosense Webster, Inc./Johnson & Johnson
  5. Boston Scientific Corporation
  6. GE Healthcare/General Electric Company
  7. Medtronic, Inc.
  8. Philips Healthcare/Royal Philips Electronics NV
  9. St. Jude Medical, Inc.
  10. ZOLL Medical Corporation
Contact Us

Need help finding medtech research? Let us help you!